Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael Natrajan

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Endocrine-Related Cancer|June 1, 2018
Splicing dysregulation as a driver of breast cancerAbigail Read, Rachael Natrajan
Journal of the National Cancer Institute|May 1, 2016
Risk Stratification and Intrinsic Subtype Classification of Breast Cancer: a Multi-Parameter Test to Rule Them All?Rachael Natrajan, Britta Weigelt
Cancer Research|June 7, 2013
From integrative genomics to therapeutic targetsRachael Natrajan, Paul Wilkerson
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Identification and Validation of Driver Kinases from Next-Generation Sequencing DataAndri Leonidou, Barrie Peck, Rachael Natrajan
The Journal of Pathology|August 16, 2023
Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancerShefali Thakur, Syed Haider, Rachael Natrajan
Expert Review of Molecular Diagnostics|May 7, 2011
Next-generation sequencing applied to molecular diagnosticsRachael Natrajan, Jorge S Reis-Filho
The Journal of Pathology|June 1, 2022
Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers<sup>‡</sup>Saira Khalique, Sarah Nash, Rachael Natrajan
Cancer Discovery|March 4, 2018
Driver Oncogenes but Not as We Know Them: Targetable Fusion Genes in Breast CancerRachael Natrajan, Andrew N J Tutt, Christopher J Lord
Seminars in Cancer Biology|November 8, 2019
Translational genomics of ovarian clear cell carcinomaSaira Khalique, Christopher J Lord, Susana Banerjee, et al.
NPJ Breast Cancer|December 22, 2021
Subclonal heterogeneity and evolution in breast cancerIoanna Mavrommati, Flora Johnson, Gloria V Echeverria, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Endocrine-Related Cancer|June 1, 2018
Splicing dysregulation as a driver of breast cancerAbigail Read, Rachael Natrajan
Journal of the National Cancer Institute|May 1, 2016
Risk Stratification and Intrinsic Subtype Classification of Breast Cancer: a Multi-Parameter Test to Rule Them All?Rachael Natrajan, Britta Weigelt
Cancer Research|June 7, 2013
From integrative genomics to therapeutic targetsRachael Natrajan, Paul Wilkerson
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Identification and Validation of Driver Kinases from Next-Generation Sequencing DataAndri Leonidou, Barrie Peck, Rachael Natrajan
The Journal of Pathology|August 16, 2023
Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancerShefali Thakur, Syed Haider, Rachael Natrajan
Expert Review of Molecular Diagnostics|May 7, 2011
Next-generation sequencing applied to molecular diagnosticsRachael Natrajan, Jorge S Reis-Filho
The Journal of Pathology|June 1, 2022
Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers<sup>‡</sup>Saira Khalique, Sarah Nash, Rachael Natrajan
Cancer Discovery|March 4, 2018
Driver Oncogenes but Not as We Know Them: Targetable Fusion Genes in Breast CancerRachael Natrajan, Andrew N J Tutt, Christopher J Lord
Seminars in Cancer Biology|November 8, 2019
Translational genomics of ovarian clear cell carcinomaSaira Khalique, Christopher J Lord, Susana Banerjee, et al.
NPJ Breast Cancer|December 22, 2021
Subclonal heterogeneity and evolution in breast cancerIoanna Mavrommati, Flora Johnson, Gloria V Echeverria, et al.
Pageof 12